Bioavailability of Belumosudil (KD025) in Healthy Male Subjects
Status:
Completed
Trial end date:
2016-02-19
Target enrollment:
Participant gender:
Summary
Phase 1 bioavailability study to evaluate the pharmacokinetics (PK) and tolerability/safety
of the belumosudil tablet formulation in the fasted and fed states and compared to the
belumosudil capsule formulation in the fed state.